People: GlaxoSmithKline PLC (GSK)
38.47USD
4:00pm EST
$0.35 (+0.92%)
$38.12
$38.26
$38.75
$37.95
3,263,009
2,316,888
$43.47
$27.15
Heslop, Julian
Brief Biography
Mr. Julian Heslop serves as Chief Financial Officer and Executive Director of GlaxoSmithKline PLC and was appointed on April 1, 2005. Mr. Heslop joined Glaxo Wellcome as Financial Controller in April 1998. In January 2001 he was appointed Senior Vice President, Operations Controller. Prior to joining the Group he held senior finance roles at Grand Metropolitan.
Basic Compensation
| Total Annual Compensation, GBP | Long-Term Incentive Plans, GBP | All Other, GBP | Fiscal Year Total, GBP |
|---|---|---|---|
| 926,000 | -- | -- | 926,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Gent, Christopher | 651,000 |
| Witty, Andrew | 1,778,000 |
| Heslop, Julian | 926,000 |
| Slaoui, Moncef | 2,152,000 |
| Dunoyer, Marc | -- |
| Pulman, David | -- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
